Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate

Takeda Pharmaceutical (TAK) and AC Immune (ACIU) said Monday they have agreed to an exclusive, worldwide option and license agreement for AC Immune's immunotherapies, including its Alzheimer's disease treatment candidate.

MT NewswiresMay 13 07:26 ET

Top Gap Ups and Downs on Monday: TM, BABA, STLA and More

Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.

moomoo News19:50 ET

Sector Update: Health Care

Health care stocks were mixed late Monday afternoon with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.2%. The iShares Biotechnology ETF (IBB) added

MT Newswires15:37 ET

Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?

Monday, Takeda Pharmaceutical Company Limited (NYSE:TAK) and AC Immune SA (NASDAQ:ACIU) announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies targeting

Benzinga13:46 ET

AC Immune Enters Licensing Deal for Alzheimer's Disease Drug Candidate

AC Immune SA (IMR.F) said Monday it signed an exclusive option and license agreement with Japan's Takeda Pharmaceutical (TKD.F) for the former's ACI-24.060, a potential Alzheimer's disease drug treatm

MT NewswiresMay 13 10:18 ET

AC Immune Rockets 47% on Alzheimer's Therapy Deal With Takeda

Seeking AlphaMay 13 09:52 ET